What Sanofi Early Research Chief Scientist Frank Nestle Is Most Excited About

Sanofi's Nestle talked to In Vivo about the company's early pipeline, the emerging technologies he thinks are most promising, and tapping external innovation.  

Sanofi
• Source: Shutterstock

Sanofi's approach to drug discovery and early pipeline development has been changing over the last five years, and its global head of research and chief scientific officer Frank Nestle told In Vivo that some of the investment is beginning to deliver promising new drug candidates.

"It's a science-led organization with a cultural drive, with a play-to-win attitude and a portfolio that is evolving but already...

More from New Science

More from In Vivo